Obama Nominates Dr. Robert Califf to Lead FDA

Sept. 16, 2015
President Obama has nominated the Food and Drug Administration's second-highest ranking official, Dr. Robert Califf, to lead the agency.

President Barack Obama has nominated the Food and Drug Administration's second-highest ranking official, Dr. Robert Califf, to lead the agency, which regulates consumer products ranging from medications to seafood to cigarettes.

The White House announced the move on Sept. 15 in a statement naming officials nominated for various federal posts. If confirmed by the Senate, Califf would take over at a critical time for the agency, which is under pressure from Congress to streamline regulations for medical products.

Califf spent most of his career in academia, but is well versed in FDA issues, especially the clinical testing of drugs and medical devices. He previously served on expert committees that advise the FDA and was considered for the commissioner's job at least twice before — once under President George W. Bush and once earlier in the Obama administration.

The commissioner position is subject to pressure from assorted outside interests, such as multinational corporations, politicians, consumer advocates and medical professionals. Most of the recent FDA commissioners have stayed on the job for less than three years.

If named head of the FDA, Califf would inherit various projects and potential challenges, including ongoing food safety and labeling reforms, unfinished tobacco regulations and proposals from Republican lawmakers focused on streamlining drug reviews.

Califf's background as a drug researcher could make him receptive to some of the reforms coming out of Congress, though he hasn't testified or spoken publicly about the legislation.

Currently the FDA's chief scientist, Dr. Stephen Ostroff, is serving as acting head of the agency.

Sponsored Recommendations

Revolutionizing Healthcare: The Impact of Digitalization in Biopharma Innovation

Biopharma enables an entirely new level of innovation that’s simply not possible in conventional drug development. It’s an approach that can fundamentally change the way healthcare...

Navigating the Automotive Industry's Electric Future

The automotive industry is at a turning point. Bloomberg estimates that by 2040, 54% of new vehicle sales will be electric. And by 2030, we’re looking at 100% of passenger vehicles...

Unified Process Control Brings Operational Clarity

Inland Empire Utilities Agency replaces its SCADA enterprise system with the PlantPAx Distributed Control System and reduces complexity for operators

PlantPAx DCS Improves Operational Reliability

KC Water calls on R.E. Pedrotti to replace obsolete wastewater SCADA solution with a unified Modern Distributed Control System (DCS).